Metastatic Melanoma Among People of Color

If you’ve ever heard someone say, “Melanoma isn’t really a thing for darker skin,” please picture me gently sliding that myth into the recycling bin where it belongs. People of color can get melanoma. And when melanoma shows up lateafter it has spread (metastasized)it becomes a much tougher opponent. The extra-tricky part? In many people with darker skin tones, melanoma often appears in places most folks don’t think to check: palms, soles, nailbeds, and certain mucous membranes. In other words: melanoma sometimes plays hide-and-seek, and it’s annoyingly good at hiding.

This article breaks down what metastatic melanoma means, why it can be diagnosed later in people of color, what signs deserve a closer look, and how today’s treatments (including modern immunotherapy and targeted therapy) fit into the picture. It’s educationalnot a substitute for medical careso if something on your skin is new, changing, or just plain suspicious, a clinician’s eyes beat Google’s every time.

What “Metastatic Melanoma” Actually Means

Melanoma begins in pigment-producing cells (melanocytes). “Metastatic” melanoma means the cancer has spread beyond the original siteoften to lymph nodes or distant organs. Clinically, you’ll hear terms like “advanced,” “unresectable,” or “stage IV,” and the theme is the same: the disease isn’t confined to one small neighborhood anymore.

Melanoma can spread to places like the lungs, liver, brain, bones, or distant lymph nodes. Symptoms vary depending on where it travelssometimes it’s swollen nodes, persistent cough, unexplained headaches, bone pain, fatigue, or weight loss. Sometimes it’s none of those at first, which is why earlier detection matters so much.

The Big Paradox: Lower Incidence, Higher Risk of Late Diagnosis

In the U.S., melanoma is diagnosed far more often in non-Hispanic White populations than in many other racial and ethnic groups. But “less common” is not the same as “not a concern.” When melanoma occurs in people of color, multiple studies and surveillance reports show it is more likely to be found at later stages.

For example, CDC data analyzing melanoma among non-Hispanic Black Americans (2011–2015) found a smaller proportion diagnosed at localized stage and a higher proportion diagnosed with distant metastasis compared with non-Hispanic White patients. That same analysis reported lower overall 5-year melanoma survival for non-Hispanic Black populations compared with non-Hispanic White populations, with survival strongly tied to stage at diagnosis. (Translation: stage matters, and timing matters.)

Meanwhile, SEER stage-based survival statistics show that when melanoma is “distant” (metastatic), the 5-year relative survival rate is roughly in the mid-30% range overall. These are population-level estimateshelpful for perspective, not destiny for any individualbut they underscore why “catch it sooner” is not just a slogan.

Why Melanoma Can Be Missed in Skin of Color

Late diagnosis is rarely one single issue. It’s usually a stack of factorssome medical, some social, some systemicthat line up like unhelpful dominoes. Here are the big ones that show up again and again:

1) Location: Not Where People Expect It

In skin of color, melanoma is more likely to appear on areas that don’t get much sun exposurelike the palms, soles, and under/around nails. Many people simply don’t check those areas, and some clinicians may be less suspicious there at first glance.

2) Subtype: Acral Lentiginous Melanoma (ALM)

Acral lentiginous melanoma (ALM) occurs on palms, soles, and nail units. It’s relatively rare overall, but it makes up a much larger share of melanomas diagnosed in some people of color. ALM can be confused with bruises, blood blisters, warts, fungal issues, or “just a weird spot,” which delays evaluation. Importantly, ALM does not appear to be driven by UV exposure the way many other melanomas areso the usual “sunburn story” may be absent.

3) Pattern Recognition: The “Teaching Image Gap”

Medical training resources and public awareness campaigns have historically shown more examples of skin cancer on lighter skin. If people don’t see themselves in the imagesor if clinicians have fewer reference pointsdiagnosis can slow down. That’s not a moral failing; it’s a fixable education problem.

Where to Look: High-Yield Spots for People of Color

A practical takeaway: don’t limit skin checks to sun-exposed areas. For many people of color, the “usual suspects” for melanoma may be in places that feel oddly protected.

Palms and Soles

Look for new or changing spots, patches, or lesionsespecially anything that grows, changes color, bleeds, or won’t heal. On soles, melanoma can masquerade as a stubborn callus or a persistent “bruise” that never got the memo to fade.

Under and Around Nails (Subungual Melanoma)

Nail melanoma may appear as a dark streak or irregular pigmentation under the nail, sometimes with pigment spreading to nearby skin. It can be mistaken for trauma, infection, or a “normal” pigment bandespecially in people of color who may have benign nail pigmentation. The red flags are change over time, a single nail progressively worsening, nail splitting/destroying, bleeding, or pain.

Mucosal Sites and Eyes

Melanoma can occur in mucous membranes (mouth, nasal passages, genital/anal areas) and in the eye (ocular melanoma). These are rarer, but they’re part of why relying only on the classic “mole on the back” mental image can be misleading. If you have persistent, unexplained symptoms in these areas, bring them upyes, even if it’s awkward. Cancer doesn’t care about awkward.

Warning Signs: ABCDE…and When It’s Not Enough

Many people have heard the ABCDE guide for suspicious moles (Asymmetry, Border, Color, Diameter, Evolving). It can be helpfulbut it may not catch everything, especially ALM on hands/feet or nail units. Some melanoma specialists recommend using a different prompt for acral lesions called CUBED: Color (new/odd pigmentation), Uncertain diagnosis (you can’t explain it), Bleeding, Enlargement, and Delay in healing.

If a spot on your palm/sole/nail is persistently changing or not healing, that alone is worth a professional look. You don’t need the lesion to hit every letter of any acronym to justify an appointment. The goal isn’t to “win the alphabet game”it’s to get clarity.

How to Get Diagnosed Faster (Without Turning Into a Hypochondriac)

Early detection doesn’t require paranoia. It requires a routine. Here’s a realistic approach that respects both your time and your mental health:

Do a Monthly “Weird Spot” Scan

• Check palms and between fingers.
• Check soles, heels, and between toes (a hand mirror helps).
• Look at nails (fingers and toes), including the skin around them.
• Don’t ignore mucosal symptoms that persist (mouth sores, unexplained bleeding, etc.).

Track Changes Like You’re a Scientist (A Casual Scientist)

Photos can help you notice change over timesize, shape, color, or texture. If something evolves over weeks to months, that history is valuable in the exam room.

Ask for a Full-Body Skin Exam When Appropriate

Many dermatology organizations recommend regular skin checksespecially for people with risk factors (family history, lots of moles, prior skin cancer, immunosuppression). Even without classic risk factors, people of color benefit from awareness that melanoma may appear in less sun-exposed areas. If you’re unsure, ask your clinician what schedule makes sense for you.

Systemic Factors: The Part We Don’t Fix With “Just Be More Careful”

It would be nice if the whole solution were “check your feet more.” But healthcare disparities aren’t that polite. Delays can happen because of limited access to dermatology, fewer clinicians trained with diverse images, and lower suspicion of melanoma in darker skin. Fixing metastatic melanoma outcomes among people of color requires both personal vigilance and system-level improvements: better training, better access, better public messaging, and more inclusive clinical research.

Treatment for Metastatic Melanoma: What’s Changed (and Why That Matters)

The treatment landscape for metastatic melanoma has changed dramatically in the modern era, mainly thanks to immunotherapy and targeted therapies. Treatment decisions depend on factors like tumor genetics (for example, whether a BRAF mutation is present), where the cancer has spread, symptoms, overall health, and prior treatments.

Immunotherapy (Checkpoint Inhibitors and Beyond)

Immune checkpoint inhibitors help the immune system recognize and attack cancer by releasing certain “brakes.” Common approaches include PD-1 inhibitors (often used broadly in melanoma), combination regimens (in selected situations), and newer immune targets. These treatments can produce long-lasting responses in some patients, but they can also cause immune-related side effects that require close monitoring.

Targeted Therapy (When the Tumor Has a Target)

If melanoma has a BRAF mutation, targeted therapy using BRAF and MEK inhibitors can be effective, often working quickly. A major challenge is that resistance can develop over time, which is one reason clinicians consider sequencing strategies and clinical trials.

Surgery and Radiation (Still in the Game)

Even in metastatic disease, surgery may be used in select cases (for example, limited metastases), and radiation can help control symptoms or treat specific sites such as brain metastases or painful bone lesions. Care is often multidisciplinaryoncology, dermatology, surgery, radiation oncologybecause melanoma doesn’t do “simple.”

Clinical Trials and Emerging Options (Including Cellular Therapy)

Clinical trials remain a key option in metastatic melanomaespecially when standard treatments stop working or when a patient’s tumor biology suggests a novel approach. One example of newer progress is tumor-infiltrating lymphocyte (TIL) therapy, a form of cellular immunotherapy that uses a patient’s own immune cells. It has been used for advanced melanoma in specialized centers and reflects the broader trend: melanoma care keeps evolving.

Prognosis: Numbers That Inform, Not Define

Let’s talk survival rates with the respect they deserveand the boundaries they require. SEER-based statistics estimate that metastatic (“distant”) melanoma has a 5-year relative survival rate around the mid-30% range overall. That sounds stark, and it is.

But two important notes: (1) These numbers reflect groups of patients diagnosed in prior years and can lag behind the newest treatment improvements. (2) Individuals are not averages. Some people respond exceptionally well to immunotherapy and live many years; others need multiple lines of therapy. The right way to use survival statistics is as a conversation starter with your oncology team, not as a personal prophecy.

Practical Prevention (Yes, Even for Darker Skin)

Melanin offers some UV protection, but it doesn’t make skin invincible. Sun protection still mattersespecially to reduce overall skin damage and risk. More importantly for melanoma among people of color: prevention also includes early detection habits and pushing past the myth that “it can’t happen to me.”

• Use broad-spectrum sunscreen on exposed skin when outdoors.
• Skip tanning beds (melanoma risk does not need a hobby).
• Learn your baseline: moles, freckles, nail bandswhat’s normal for you.
• Check palms/soles/nails monthly; schedule clinician exams when appropriate.

Conclusion: The Goal Is Earlier, Fairer, Better

Metastatic melanoma among people of color is not just a biology storyit’s also a visibility story. When melanoma is less expected, it’s found later. When it’s found later, outcomes suffer. The fix is part awareness (knowing where melanoma can hide), part access (getting timely dermatologic evaluation), and part modernization (using today’s therapies and clinical trials wisely).

If you remember only one thing: check the places you don’t usually check. Your feet, nails, and palms deserve at least the same attention you give your phone screenpreferably more, because your phone has never saved your life. Your skin might.

Experiences That Often Show Up in Real Life (And What They Teach Us)

The stories below are composite experiences drawn from common patterns clinicians and patient organizations discussshared here to make the “why” feel human. They are not medical advice, and they’re not meant to replace professional evaluation. They’re meant to help you recognize situations that people frequently describe on the road to (and through) metastatic melanoma.

The “It’s Just a Bruise” Foot Spot

A frequent experience: someone notices a dark patch on the sole of the foot. It doesn’t hurt. It’s not where the sun hits. It feels logical to blame new shoes, a long day of walking, a workout, or stepping on a Lego (the true enemy). Weeks pass. The spot doesn’t fade. Sometimes it thickens, cracks, or starts to bleed. It gets treated like a callus. Or it’s filed down at home. Or it’s ignored because the last thing anyone wants is another appointment on the calendar.

The lesson: acral melanoma can be sneaky. If a “bruise” or “callus” is persistent, enlarging, bleeding, or not healing, it deserves a clinician’s look. Waiting doesn’t make the appointment easierit just makes the problem more complicated.

The Nail Streak That Slowly Becomes the Main Character

Another common pattern: a single nail develops a dark band. For many people of color, benign nail pigment bands can be normalso the streak feels familiar, not alarming. But this one changes. It widens. The nail becomes brittle or distorted. The surrounding skin may darken. Sometimes it’s dismissed as trauma (“I hit it somewhere”), or treated as infection (“maybe fungus?”), or simply watched without a plan.

The lesson: benign pigment bands usually stay stable and often involve multiple nails. A changing band in one nailespecially with nail damage, bleeding, or pigment extending to nearby skinshould be evaluated.

The Diagnosis That Arrives Late, Loud, and Life-Rearranging

Many people describe a strange emotional whiplash: “I thought melanoma was a ‘fair skin’ problem” collides with a diagnosis that has already advanced. The early weeks can be a blur of scans, biopsies, acronyms, and treatment decisions. People often say the hardest part is not just the fear it’s the speed at which life changes. Work plans shift. Family roles shuffle. Everyone becomes a part-time medical scheduler.

The lesson: support systems matter as much as treatment plans. Patients commonly benefit from bringing someone to appointments, writing questions down, and asking for resources (patient navigators, financial counseling, transportation help, mental health support). This is not “extra.” It’s part of care.

The “I Didn’t Feel Heard” Appointment Loop

Some patients of color describe feeling minimized early on: the lesion is called “probably nothing,” or there’s an assumption that melanoma is unlikely, or there’s no full-skin exam because the concern is focused on a single spot. Sometimes this is simple probability-thinking. Sometimes it’s time pressure. Sometimes it’s lack of exposure to how melanoma can look on darker skin. But the result can be the same: delay.

The lesson: it’s okay to advocate for yourself. If something is new, changing, bleeding, enlarging, or not healing, say so clearly. Ask, “If it’s not this, what is itand what’s the plan to confirm that?” A respectful second opinion is also a normal part of modern healthcare.

Living With Treatment: Hope, Side Effects, and a New Vocabulary

People undergoing immunotherapy often describe a strange mix: optimism (because modern treatments can work remarkably well) plus vigilance (because side effects can be serious). They learn terms like “immune-related adverse events,” and they become highly attuned to new symptomsdiarrhea that won’t quit, shortness of breath, rash, fatigue that feels like walking through wet cement. They learn the difference between “normal tired” and “call the clinic tired.”

The lesson: communication saves timeand sometimes health. Patients frequently say their best outcomes came from reporting symptoms early and treating side effects promptly, rather than trying to “tough it out.”

What Caregivers Often Say (But Don’t Always Say Out Loud)

Caregivers commonly describe a quiet kind of strain: wanting to be strong, not wanting to scare the patient, and still needing a place to fall apart. They may juggle work, childcare, transportation, and insurance paperwork while also trying to be emotionally present. Humor becomes a pressure valvesometimes the only one available.

The lesson: caregiving needs support too. Many cancer centers and patient organizations offer caregiver groups and counseling. Taking that help is not a luxury; it’s maintenance.

If you’re taking anything from these experiences, let it be this: melanoma in people of color is often missed not because people don’t care, but because the disease frequently shows up in unexpected places and doesn’t match the “classic” picture. Awarenesspaired with timely medical evaluationcan shift the timeline earlier, when treatment is more straightforward and outcomes are better.